Trial Profile
Pilot Study of Acthar Gel in Chronic Inflammatory Demyelinating Neuropathy
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 20 Jul 2016
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Chronic inflammatory demyelinating polyradiculoneuropathy
- Focus Adverse reactions
- 15 Jul 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 17 Oct 2015 New trial record